[1]
Sara Zahra Omidi, “TARGETING TYPE I INTERFERON SIGNALING IN SYSTEMIC LUPUS ERYTHEMATOSUS: CLINICAL AND SAFETY PERSPECTIVES ON ANIFROLUMAB THERAPY”, IJITSS, vol. 2, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5467.